PTC Therapeutics, Inc.
PTCT
$48.19
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 42.02% | 29.38% | 22.41% | -1.40% | -12.09% |
| Total Depreciation and Amortization | -68.02% | -23.18% | 22.73% | 71.42% | 83.64% |
| Total Amortization of Deferred Charges | -36.04% | -44.88% | -25.62% | -7.68% | -1.47% |
| Total Other Non-Cash Items | -66.63% | -17.30% | -9.95% | 60.29% | 40.32% |
| Change in Net Operating Assets | 2,616.69% | -138.49% | -700.69% | 219.72% | 95.78% |
| Cash from Operations | 32.02% | 20.58% | 53.36% | 79.86% | 55.58% |
| Capital Expenditure | 77.14% | 73.64% | 53.68% | 15.82% | 11.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.26% | -1,736.74% | -317.32% | -195.84% | -146.03% |
| Cash from Investing | 125.00% | -537.43% | -362.45% | -223.82% | -160.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.51% | -21,762.94% | -99.16% | -99.16% | -99.22% |
| Issuance of Common Stock | 12.57% | -69.98% | -67.66% | 8.55% | 42.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.64% | 2,289.77% | 2,328.15% | 1,864.10% | 1,869.94% |
| Cash from Financing | -60.42% | 158.45% | 369.53% | 276.20% | 284.87% |
| Foreign Exchange rate Adjustments | -335.32% | -26.81% | -71.28% | 173.03% | 212.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.14% | 488.48% | 783.66% | 304.11% | 218.48% |